Recurrent Small Lymphocytic Lymphoma
Showing NaN - NaN of 14
Grade 3a Follicular Lymphoma, Recurrent Follicular Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Houston (other,
Completed
- Grade 3a Follicular Lymphoma
- +9 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 31, 2023
Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,
Active, not recruiting
- Prolymphocytic Leukemia
- +2 more
- Ibrutinib
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 7, 2022
Chronic Lymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +5 more
- Ibrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in
Recruiting
- Recurrent Chronic Lymphocytic Leukemia
- +3 more
- Acalabrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Hematopoietic and Lymphoid Cell Tumor, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +5 more
- Ibrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
Loss of Chromosome 17p, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Houston (drug,
Completed
- Loss of Chromosome 17p
- +5 more
- Ibrutinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 4, 2022
B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Chronic
Terminated
- B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged
- +16 more
- Autologous CD19-CD8-CD28-CD3zeta-CAR-mbIL15-HER1t T Cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 28, 2021
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +35 more
- Akt inhibitor MK2206
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Oct 14, 2020
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +45 more
- anti-endosialin/TEM1 monoclonal antibody MORAb-004
- +2 more
-
Birmingham, Alabama
- +19 more
Jan 7, 2016
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Houston (recombinant
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +16 more
- recombinant interleukin-12
- laboratory biomarker analysis
-
Houston, TexasM D Anderson Cancer Center
Apr 14, 2015
Cutaneous B-cell Non-Hodgkin Lymphoma, MALT, Intraocular Lymphoma Trial in Houston (oblimersen sodium, rituximab, laboratory
Completed
- Cutaneous B-cell Non-Hodgkin Lymphoma
- +20 more
- oblimersen sodium
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 13, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +50 more
- Akt inhibitor MK2206
- +2 more
-
Birmingham, Alabama
- +24 more
Apr 28, 2014
Angioimmunoblastic T-cell Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Houston (nelarabine)
Terminated
- Angioimmunoblastic T-cell Lymphoma
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013
Angioimmunoblastic T-cell Lymphoma, MALT, Nodal Marginal Zone B-cell Lymphoma Trial in Houston (oxaliplatin)
Completed
- Angioimmunoblastic T-cell Lymphoma
- +16 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013